Company: THC
Filing Date: 2025-10-28
Form Type: 10-Q
Source: 0000070318-25-000046
Chunk: 55

Company: TENET HEALTHCARE CORP
Filing Date: 2025-10-28
Form: 10-Q
Item: Part I, Item 1
Chunk 55
---
)Repurchases of common stock(795)— — — — (124)— (124)Stock-based compensation expense, tax benefit and issuance of common stock59 — 17 — — — — 17 Balances at September 30, 202495,083 $8 $4,849 $(175)$2,690 $(3,538)$1,592 $5,426 Nonredeemable Noncontrolling InterestsThe table below presents our nonredeemable noncontrolling interests balances by segment: September 30, 2025December 31, 2024Hospital Operations$204 $205 Ambulatory Care1,565 1,444 Total nonredeemable noncontrolling interests$1,769 $1,649 The table below presents our income available to nonredeemable noncontrolling interests by segment: Three Months EndedSeptember 30,Nine Months EndedSeptember 30, 2025202420252024Hospital Operations$9 $14 $33 $35 Ambulatory Care97 81 273 239 Total net income available to nonredeemable noncontrolling interests$106 $95 $306 $274 

13

Share Repurchase Program ActivityIn October 2022, our board of directors authorized the repurchase of up to $1.000 billion of our common stock through a share repurchase program (the “2022 share repurchase program”). This program allowed for share repurchases to be made in open‑market or privately negotiated transactions, at management’s discretion subject to market conditions and other factors, and in a manner consistent with applicable securities laws and regulations. The program did not require us to acquire any particular amount of common stock and could be suspended for periods or discontinued at any time. In July 2024, our board authorized a new share repurchase program (the “2024 share repurchase program”) of up to an additional $1.500 billion of our common stock with no expiration date, under terms substantially similar to the 2022 share repurchase program. We did not make any additional repurchases under the 2022 share repurchase program following the approval of the 2024 share repurchase program. In July 2025, our board of directors authorized a $1.500 billion increase to the 2024 share repurchase program.The table below presents repurchase activity under both